We are excited to welcome you to the ASHG 2024 Annual Meeting which will take place November 5-9 in Denver, Colorado. You can expect to experience five full days of exciting science including special sessions such as the Presidential Symposium, Presidential Address, and industry-education events! Attendees will also have ample opportunities for collaboration whether it be in... Read More
Posted By: Kylee Spencer, PhD, Assistant Editor, AJHG KS: What motivated you to start working on this project? HW: We know from eQTL studies that trans-acting loci tend to have smaller effect sizes than cis-acting loci. By aggregating cis-acting effects into one predicted expression level, as is done in the TWAS method PrediXcan, we had... Read More
For Immediate Release: Thursday, February 15, 2024, 3:00pm U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD - The American Society of Human Genetics (ASHG) is excited to announce the selection of Amanda Perl as the organization’s next Chief Executive Officer. Perl has served in numerous association leadership positions with deep experience in strategic... Read More
Posted By: Kylee Spencer, PhD, Assistant Editor, AJHG KS: What motivated you to start working on this project? SG: Tumor Mutational Burden (TMB) is one of a few FDA approved biomarkers for immunotherapy in solid tumors but the mechanisms for why certain tumors are TMB-high and why certain TMB-high tumors still do not respond to... Read More
Posted By: Kylee Spencer, PhD, Assistant Editor, AJHG KS: What motivated you to start working on this project? DF: I initially trained as a chemist, so I’m surprised to have written this paper about variants of uncertain significance. I moved from chemistry to genomics because it was, and still is, a hotbed of technological development.... Read More